期刊
EMERGING INFECTIOUS DISEASES
卷 22, 期 7, 页码 1253-1256出版社
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2207.151319
关键词
-
资金
- Pfizer [WS79560E]
- Veterans Health Administration Health Services Research and Development Career Development Award [CDA 11-215]
- VA HSRD grant [IIR 09-099]
- Cubist Pharmaceuticals
- Cerexa, a subsidiary of Forest Laboratories
We retrospectively analyzed data for 195 respiratory infection patients who had positive Staphyloccocus aureus cultures and who were hospitalized in 2 hospitals in Iowa and Maryland, USA, during 2003-2009. Odds for death for patients who also had influenza-positive test results were >= 4 times higher than for those who had negative influenza test results.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据